Prognostic Analysis of Primary Pulmonary Malignant Mesenchymal Tumors Treated Surgically

BACKGROUND: Primary pulmonary malignant mesenchymal tumors are rare, constituting only 0.4% of all lung cancers. Since sarcomas are chemo/radio-resistant, surgical resection is the optimal treatment choice for patients with suitable medical conditions and tumor stage. In the present study, we analyz...

Descripción completa

Detalles Bibliográficos
Autores principales: Sayan, Muhammet, Kankoc, Aykut, Ozkan, Dilvin, Celik, Ali, Kurul, Ismail Cuneyt, Tastepe, Abdullah Irfan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Thoracic and Cardiovascular Surgery 2021
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548186/
https://www.ncbi.nlm.nih.gov/pubmed/34376628
http://dx.doi.org/10.5090/jcs.21.032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548186/
https://www.ncbi.nlm.nih.gov/pubmed/34376628
http://dx.doi.org/10.5090/jcs.21.032

Ejemplares similares